Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions
- 1 June 1987
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 94 (6) , 559-567
- https://doi.org/10.1111/j.1471-0528.1987.tb03151.x
Abstract
The effects on lipid metabolism of seven combined oral contraceptives were investigated, particularly the effects on high density lipoprotein (HDL) subfractions, which were separated by density gradient ultracentrifugation. There were no differences between the preparations in the effects on the LDL fraction, the so-called atherogenic particle, but there were marked differences in the effects on the anti-atherogenic HDL fraction, of which the effects on HDL-2 were most pronounced. After treatment with monophasic cyproterone acetate and biphasic desogestrel, the cholesterol and phospholipid contents of the HDL-2 fraction were significantly higher than those found after treatment with the other preparations. The lowest values were found after treatment with monophasic levonorgestrel, whereas monophasic desogestrel, triphasic levonorgestrel, monophasic norethisterone and triphasic gestoden induced intermediate values for these variables. The levels of HDL-2 reflect the intrinsic androgenicity of the various progestogens used in the preparations.Keywords
This publication has 25 references indexed in Scilit:
- Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoproteinAtherosclerosis, 1985
- PROGESTAGENS AND HIGH-DENSITY LIPOPROTEINSThe Lancet, 1984
- PROGESTAGENS AND HIGH-DENSITY LIPOPROTEINSThe Lancet, 1984
- DOES THE NEW PROGESTAGEN DESOGESTREL HAVE METABOLIC ADVANTAGES?The Lancet, 1984
- Binding of progestagens to receptor proteins in MCF-7 cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activityAtherosclerosis, 1981
- Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.BMJ, 1981
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- THE TROMSØHEART-STUDYThe Lancet, 1977